Future research in neonatal and developmental gastroenterology should include inquiry well beyond finding a cure or better preventative measures against necrotizing enterocolitis. The gastrointestinal (GI) tract acts not only as a digestive-absorptive organ; it also serves major endocrine and neural functions. It encompasses a vast surface area exposed to the external environment and plays a major role in both innate and adaptive immunity. Numerous short-and long-term health benefits could be derived from a better understanding of the developing GI tract. Journal of Perinatology (2006) 26, S19-S22. doi:10.1038/sj.jp.7211424
The most common and life threatening gastrointestinal problem that directly concerns the neonatologist is necrotizing enterocolitis (NEC). However, successful treatment and prevention of NEC is only a small component of the overall impact that a better understanding of the developing gastroenterology (GI) tract could encompass.
The purpose of this review is to suggest important areas of future research in neonatal and developmental GI that could impact both short and long term health. This review will be limited to three:
(1) How can we use the GI tract safely to minimize the use of parenteral nutrition? (2) How can we harness the GI microbiota and innate immune system to ameliorate hospital-acquired infections and systemic inflammation? (3) Can we manipulate the GI tract and nutrition in early life to prevent long-term chronic illnesses such as type-1 diabetes, allergies or asthma?
Using the immature GI tract and decreasing parenteral nutrition The critically ill, low birth weight infants' GI tract is either not used at all for several weeks after birth or provided with 'minimal enteral nutrition.' Considerable evidence is accumulating that this approach is far from ideal. Studies in animals and adult humans have shown that a lack of luminal nutrients results in mucosal atrophy, a lack of stimulation of trophic hormones, sepsis, increased polymorphonuclear attraction and an increased likelihood to development of the systemic inflammatory response syndrome (SIRS) 1 ( Figure 1 ). The intestinal surface epithelium is polarized with an apical microvillus surface that usually derives most of its nutrients from the luminal rather than the basal surface. As a result of higher requirements for intestinal growth in the neonatal period, the lack of luminal nutrients may even be more important in the infant than that in the adult. It is reasonable to posit that a lack of luminal nutrients may actually underlie some of the nonintestinal pathology seen in the NICU, such as hospital-acquired sepsis and chronic lung disease.
A lack of nutrients in the GI tract in the last trimester of pregnancy is an anomaly. A continuous flux of amniotic fluid through the GI tract during the last trimester of pregnancy is a component of normal physiology because the fetus swallows approximately 450 ml of amniotic fluid per day. This is suddenly interrupted at the time of premature birth. The extrauterine and intrauterine environments are quite different, and the foods currently available to the premature infant are very different than amniotic fluid. Even if amniotic fluid were available, the intestinal environment is no longer sterile and the nutritional needs for the GI tract would likely be quite different than the in utero needs. An understanding of the anatomic, mechanical and digestive absorptive aspects of intestinal development should aid in finding ways to improve the capability of the premature infant to safely utilize the GI tract for nutrition. Two specific areas of interest relate to mechanical problems and the increasing surface area and subsequent digestive absorptive capability.
Mechanical problems include suck-swallow incoordination, which necessitates tube feeding; poor esophageal sphincter tone, which increases reflux; delayed gastric emptying and disorganized intestinal motility, which lead to feeding intolerance and intestinal stasis. Currently, we have a poor understanding of the development of neurological and endocrine factors that control intestinal motility. For example, it has clearly been demonstrated that migrating motor complexes are disorganized in the immature GI tract, 2 but the mechanisms are not understood. Is this caused by a lack of development of motilin receptors, dysregulation of hormones such as peptide YY, poor neuronal innervations or a combination of these factors? Being able to dissect specific immaturities could help direct therapies, such as those, which have been accomplished with the immature lung, for example, surfactant therapy.
The surface area of the intestine is arguably the largest interface between the internal and external milieu of the body. Significant growth in length and especially mucosal surface area occurs during the last trimester of pregnancy. Do we inadvertently blunt some of this growth by our NICU feeding practices? Animals and humans that are exclusively fed by the parenteral route demonstrate a marked decrease in mucosal growth. 3 Although several physiologic benefits can be provided by minimal enteral feedings, 4, 5 one study suggested that at least 40% of nutritional requirements need to be supplied by the enteral route before significant advantages in terms of mucosal growth are elicited. 6 It is highly likely that protein provided by the enteral route would serve as a much greater stimulus for growth than similar quantities of lipid or carbohydrate. Several studies suggest that there are likely to be specific milk borne factors that are important for intestinal mucosal growth. Examples include glucagon-like peptide-2(GLP-2) 7 and several other factors found in human milk. 8 Although these factors hold promise, it is unlikely that they will provide a meaningful trophic effect to the intestine in the face of undernutrition. Relatively simple interventions such as supplying proteins in complete or hydrolyzed form to the gastrointestinal tract without the osmotic load incurred by carbohydrates and other solutes should probably be evaluated first.
Harnessing GI innate immune function to ameliorate hospital-acquired infections and systemic inflammation?
The lumen of the intestine contains approximately 10 13 microorganisms with approximately 300 000 genes, which is an order of magnitude greater than all the somatic cells and genes of the human body. 9 Several factors such as breast versus formula feeding, the use of antibiotics and/or probiotics can affect the colonization of the intestinal tract. 10 An individual consumes at least 2500 kg food antigen during a normal lifetime, but only a single layer of epithelial cells separates the luminal contents from effector immune cells in the lamina propria. Breakdown of this single layer of cells or their interepithelial junctions could lead to exposure of the antigens or microorganisms to a large array of immunologically active cells. A better understanding of this barrier and how it relates to disease is needed.
The composition of the bacteria within the intestinal lumen and their interaction, that is, 'cross-talk' with the mucosal epithelium and subepithelium also play a crucial role. 11 Commensal microorganisms have been found to maintain the proinflammatroy cytosolic nuclear factor kappa B transcription factor in a bound, inactive form in the cytoplasm of the intestinal epithelial cell. 12 Certain pathologic microorganisms have the capability to unconjugate this transcription factor from its ubiquitinated inhibitor (I kappa B), thus allowing the NF kappa B to translocate to the nucleus and induce the transcription of IL-8 and other proinflammatory mediators. These inflammatory mediators may not only lead to inflammation in the intestine, but could enter the circulation and result in a SIRS. This has been causally related to damage to organs distal to the intestine, such as the lung and the central nervous system. 13, 14 The intestinal microflora has also been demonstrated to exhibit considerable 'cross-talk' with certain intestinal epithelial cells, for example, Paneth cells found in the crypts. These cells can respond to bacterial signals by synthesizing angiogenins, cryptins, defensins and other highly active molecules that play a functional role in intestinal development, blood flow, and innate defense. 15 Our understanding of these factors during development is only beginning.
Maintaining a less inflammatory intestinal flora with the use of pro-and prebiotics may play a significant role in prevention of intestinal inflammation. In fact, research now supports the efficacy of probiotics for prevention of NEC. 16 However, the mechanism of this effect and potential complications will require additional investigations. Furthermore, certain nutrients may play a very active role in maintenance of the barrier function of the intestine, as well as downregulating inflammation. Butyrate, a short chain fatty acid produced by bacterial fermentation, has been found to play a major role in intercellular junction integrity. 17 Certain drugs that are commonly used in the neonatal intensive care unit such as indomethacin cause a breakdown of intercellular junctions. 18 Certain nutrients such as omega 3 fatty acids and amino acids such as glutamine have been found to play a potential role in the downregulation of intestinal inflammation 19, 20 and offer exciting areas for future investigation. Manipulation of the GI tract and early nutrition to prevent long-term chronic illnesses such as type-1 diabetes, allergies or asthma? The so-called 'leaky gut' has been implicated in several diseases having their origins during infancy that manifest in later life. These include atopy, food allergies, celiac enteropathy, inflammatory bowel disease [21] [22] [23] [24] the SIRS, bacterial translocation and sepsis, type-1 diabetes, 23, 25, 26 Crohn's disease 27, 28 food allergy 29 and autism. 30 Here, we will briefly focus on type-1 diabetes as a prototype. There are data to suggest that both animals and humans with a propensity to develop type-1 diabetes have an abnormal intestinal barrier. 31 Using the ratio of urinary excretion of the otherwise nonabsorbable sugars lactulose and mannitol, increased paracellular permeability prior to the development of insulitis and diabetes has been noted. 23, 25 Environmental stimuli such as infections are also known to frequently precede the onset of type-1 diabetes. 32 Some of these conditions result in alterations of the intestinal barrier that allows for increased penetration of usually nonabsorbed substances.
Preliminary studies suggest that the use of protein hydrolysate formula may be protective in the prevention of type-1 diabetes in animal models 33 and humans 34 who have a genetic susceptibility. These provide the bases for a large ongoing multicenter 'Trial to reduce IDDM in genetically at risk (TRIGR)'. The basic intestinal dysfunction leading to increased permeability in type-1 diabetes remains poorly understood and a scientific basis is needed to understand any result that may be ascertained by nutritional studies of diabetes prevention.
The mechanisms of the relationship of the developing small intestine and type-1 diabetes have begun to focus on the intestinal immune response. However, the pathogenesis may occur proximal to initiation of immune response, and can begin in the neonatal period. Could the intestinal microflora play a role? Has the intestinal microflora changed in populations that are experiencing an 'epidemic' of type-1 diabetes? The increased use of antibiotics in the food supply of developed 'clean' countries may be altering the intestinal microenvironment. The interepithelial junction is composed of several proteins, such as the occludins and claudins that perform a gatekeeper function, preventing certain antigens from penetrating the intestinal barrier. Is there a 'leaky gut' genotype that affects these proteins? Answering such questions may be critical in not only understanding type-1 diabetes but also several other diseases that may have a component of their origin in the gastrointestinal environment of the neonatal period. 24 Although the major focus of this review has been on the developing gastrointestinal tract, it is important to note that nutrition in both fetal and neonatal periods can have significant metabolic implications in later life, including effects that can pass from one generation to the next. In the human neonate, early nutrition has been linked to adult cardiovascular disease, bone health and cardiovascular function. 35 Studies in animals using early manipulation of feedings are beginning to point to mechanisms of these effects. 36 This is obviously a very important and challenging area for future research.
Summary
In summary, this review describes areas relating to the neonatal GI tract where some of our research efforts should be focused. Hopefully, the message that basic research in developmental GI and nutrition could lead to a significant translation to lifelong health is clear.
